… 3 clinical trial Submitted an sBLA for Afrezza® (insulin human) … Afrezza affirming positive outcomes utilizing inhaled insulin at the American Diabetes … to address serious unmet medical needs for those … the timing of clinical trials and reporting data; risks …

… of the pediatric indication for Afrezza, if approved, continued pipeline … to address serious unmet medical needs for those living … burden of diseases such as diabetes, nontuberculous mycobacterial (NTM) … and convenient delivery of medicines to the deep lung …

… diabetes as effectively as an injected version of the hormonal medication … have to take insulin as a drug every day, usually … had type 2 diabetes and required insulin to manage their … trial, some of the children received Afrezza as their rapid-acting insulin …

… diabetes using basal injected insulin to either placebo or inhaled insulin (Afrezza … Hopkins University School of Medicine in Baltimore, and … In a randomized controlled trial, the authors evaluated … GLP-1 receptor agonist treatments universally available. They …

… diabetes, ages 4 to 17, who participated in the trial received either Afrezza … at mealtimes, or their usual mealtime injections of insulin … of 10 diabetics don’t get treatment – study Inhaled insulin was also associated …

… trial received either Afrezza at mealtimes, or their usual mealtime injections of insulin … 2 diabetes usually start treatment with oral medications, but … personalized skin grafts, doctors take a small … S. Food and Drug Administration granted Abeona …

… the INHALE-3 trial that demonstrated technosphere insulin (Afrezza, MannKind Pharma … those assigned technosphere insulin had higher diabetes treatment satisfaction than their … observed in the adult trials. There was no … strong enough for the FDA to consider an …

… have type 1 diabetes and depend on ongoing insulin treatment to regulate their … valuable alternative to injected analogue insulin. Afrezza should be available as an … the inhaled insulin study, they are looking ahead to potential FDA approval …

… the INHALE-1 clinical trial during a “Future … insulin treatment include: Symposium – Future Ready – Breakthrough in Pediatric Type 1 Diabetes … of Prandial Technosphere Inhaled Insulin (Afrezza) Compared with Placebo … of MannKind’s Medical Education Team will be …

… trial, an adult study evaluating technosphere inhaled insulin (Afrezza) in comparison to standard diabetes … becoming a key player in diabetes trials over the last 25 years …